PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

154 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Cohrs, C.M. ; Chen, C. ; Atkinson, M.A.* ; Drotar, D.M.* & Speier, S.: Bridging the Gap: Pancreas tissue slices from organ and tissue donors for the study of diabetes pathogenesis. Diabetes 73, 11-22 (2024)
2.
Grace, S.L.* et al.: Autoantibodies to truncated GAD(96-585) antigen stratify risk of early insulin requirement in adult-onset diabetes. Diabetes, DOI: 10.2337/db23-0980 (2024)
3.
Heinitz, S. et al.: An E115A missense variant in CERS2 is associated with increased sleeping energy expenditure and hepatic insulin resistance in American Indians. Diabetes 73, 1361-1371 (2024)
4.
Wyatt, R.C.* et al.: Improved specificity of glutamate decarboxylase 65 autoantibody measurement using luciferase-based immunoprecipitation system (LIPS) assays. Diabetes 73, 565-571 (2024)
5.
Nogal, A.* et al.: A faecal metabolite signature of impaired fasting glucose: Results from twoindependent population-based cohorts. Diabetes 72, 1870-1880 (2023)
6.
Tsilingiris, D.* et al.: Sensory phenotypes provide insight into the natural course of diabetic polyneuropathy. Diabetes 73, 135-146 (2023)
7.
Wagner, R. et al.: Lower hepatic fat is associated with improved insulin secretion in a high-risk prediabetes subphenotype during lifestyle intervention. Diabetes 72, 362-366 (2023)
8.
Bediaga, N.G.* et al.: Cytotoxicity-related gene expression and chromatin accessibility define a subset of CD4+ T cells that mark progression to type 1 diabetes. Diabetes 71, 566-577 (2022)
9.
Gottmann, P.* et al.: Heterogeneous development of β-cell populations In diabetes-resistant and -susceptible mice. Diabetes 71, 1962-1978 (2022)
10.
Kwon, B.C.* et al.: Islet autoantibody levels differentiate progression trajectories in individuals with presymptomatic type 1 diabetes. Diabetes 71, 2632-2641 (2022)
11.
Scarale, M.G.* et al.: Circulating metabolites associate with and improve the prediction of all-cause mortality in type 2 diabetes. Diabetes 71, 1363-1370 (2022)
12.
Sims, E.K.* et al.: Screening for type 1 diabetes in the general population: A status report and perspective. Diabetes 71, 610-623 (2022)
13.
Yamazaki, H.* et al.: Fat-distribution patterns and future type-2 diabetes. Diabetes 71, 1937-1945 (2022)
14.
Baboota, R.K.* ; Blüher, M. & Smith, U.*: Emerging role of bone morphogenetic protein 4 in metabolic disorders. Diabetes 70, 303-312 (2021)
15.
Chen, J.* et al.: CaM kinase II-δ is required for diabetic hyperglycemia and retinopathy but not nephropathy. Diabetes 70, 616-626 (2021)
16.
Eriksson, O.* et al.: Drug occupancy assessment at the glucose-dependent insulinotropic polypeptide (GIP) receptor by positron emission tomography. Diabetes 70, 842-853 (2021)
17.
Fritsche, A. et al.: Different effects of lifestyle intervention in high- and low-risk prediabetes. Diabetes 70, 2785-2795:2785-2795 (2021)
18.
Herder, C.* et al.: Differences in biomarkers of inflammation between novel subgroups of recent-onset diabetes. Diabetes 70, 1198-1208 (2021)
19.
Li, Q.* et al.: Plasma metabolome and circulating vitamins stratified onset age of an initial islet autoantibody and progression to type 1 diabetes: The TEDDY Study. Diabetes 70, 282-292 (2021)
20.
Lundsgaard, A.M.* et al.: Small amounts of dietary medium-chain fatty acids protect against insulin resistance during caloric excess in humans. Diabetes 70, 91-98 (2021)